Arbutus Biopharma Corp. (ABUS)
4.18
-0.15
(-3.46%)
USD |
NASDAQ |
Oct 21, 16:00
4.175
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Net Income (Annual) : -33.50M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -33.50M |
| December 31, 2024 | -69.92M |
| December 31, 2023 | -72.85M |
| December 31, 2022 | -69.46M |
| December 31, 2021 | -76.25M |
| December 31, 2020 | -63.74M |
| December 31, 2019 | -153.72M |
| December 31, 2018 | -57.06M |
| December 31, 2017 | -84.41M |
| December 31, 2016 | -384.16M |
| December 31, 2015 | -61.12M |
| December 31, 2014 | -38.84M |
| December 31, 2013 | -14.06M |
| December 31, 2012 | 29.80M |
| December 31, 2011 | -10.04M |
| Date | Value |
|---|---|
| December 31, 2010 | -12.05M |
| December 31, 2009 | -8.562M |
| December 31, 2008 | -13.36M |
| December 31, 2007 | -2.383M |
| December 31, 2006 | 18.58M |
| December 31, 2005 | -7.725M |
| December 31, 2004 | -25.91M |
| December 31, 2003 | -33.55M |
| December 31, 2002 | -1.673M |
| December 31, 2001 | -15.03M |
| December 31, 2000 | -9.290M |
| December 31, 1999 | -7.968M |
| December 31, 1998 | -9.077M |
| December 31, 1997 | -6.651M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Gossamer Bio, Inc. | -170.37M |
| Legend Biotech Corp. | -297.58M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |